nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—GRIN2C—nerve—type 1 diabetes mellitus	0.0449	0.141	CbGeAlD
Ketamine—TACR1—peripheral nervous system—type 1 diabetes mellitus	0.0437	0.137	CbGeAlD
Ketamine—GRIN2B—nerve—type 1 diabetes mellitus	0.0355	0.112	CbGeAlD
Ketamine—TACR1—nerve—type 1 diabetes mellitus	0.034	0.107	CbGeAlD
Ketamine—GRIN2A—nerve—type 1 diabetes mellitus	0.031	0.0975	CbGeAlD
Ketamine—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.0246	0.0771	CbGeAlD
Ketamine—OPRM1—nerve—type 1 diabetes mellitus	0.0189	0.0593	CbGeAlD
Ketamine—SLC6A2—nerve—type 1 diabetes mellitus	0.0138	0.0434	CbGeAlD
Ketamine—DRD2—nerve—type 1 diabetes mellitus	0.0126	0.0395	CbGeAlD
Ketamine—OPRD1—kidney—type 1 diabetes mellitus	0.00948	0.0298	CbGeAlD
Ketamine—DRD2—retina—type 1 diabetes mellitus	0.00521	0.0164	CbGeAlD
Ketamine—CYP2B6—nephron tubule—type 1 diabetes mellitus	0.00397	0.0125	CbGeAlD
Ketamine—CYP2C8—kidney—type 1 diabetes mellitus	0.00389	0.0122	CbGeAlD
Ketamine—CYP2B6—cardiovascular system—type 1 diabetes mellitus	0.00357	0.0112	CbGeAlD
Ketamine—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.00353	0.0111	CbGeAlD
Ketamine—CYP2B6—kidney—type 1 diabetes mellitus	0.00349	0.011	CbGeAlD
Ketamine—PTGS1—cardiovascular system—type 1 diabetes mellitus	0.00322	0.0101	CbGeAlD
Ketamine—PTGS1—kidney—type 1 diabetes mellitus	0.00315	0.00991	CbGeAlD
Ketamine—CYP2B6—lymphoid tissue—type 1 diabetes mellitus	0.003	0.00941	CbGeAlD
Ketamine—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.00264	0.00828	CbGeAlD
Ketamine—CYP3A4—kidney—type 1 diabetes mellitus	0.00263	0.00828	CbGeAlD
Ketamine—ABCB1—retina—type 1 diabetes mellitus	0.00225	0.00708	CbGeAlD
Ketamine—ABCB1—nephron tubule—type 1 diabetes mellitus	0.00212	0.00667	CbGeAlD
Ketamine—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.00191	0.00599	CbGeAlD
Ketamine—ABCB1—kidney—type 1 diabetes mellitus	0.00187	0.00586	CbGeAlD
Ketamine—ABCB1—pancreas—type 1 diabetes mellitus	0.00185	0.00582	CbGeAlD
Ketamine—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.0016	0.00503	CbGeAlD
Ketamine—PTGS1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000193	0.000283	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000191	0.00028	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—EGFR—type 1 diabetes mellitus	0.00019	0.000278	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000189	0.000278	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000189	0.000277	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000189	0.000277	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000189	0.000277	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000188	0.000276	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ABCC8—type 1 diabetes mellitus	0.000186	0.000273	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—EGFR—type 1 diabetes mellitus	0.000185	0.000271	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000182	0.000267	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000182	0.000267	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—G6PC2—type 1 diabetes mellitus	0.000182	0.000267	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000181	0.000265	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000181	0.000265	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000181	0.000265	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—TNF—type 1 diabetes mellitus	0.000181	0.000265	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00018	0.000264	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00018	0.000264	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—TNF—type 1 diabetes mellitus	0.000176	0.000258	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000173	0.000254	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000172	0.000252	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000171	0.000251	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000171	0.00025	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.00017	0.00025	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000169	0.000248	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	0.000168	0.000247	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000167	0.000246	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000163	0.00024	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000163	0.000239	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000163	0.000238	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000161	0.000237	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000161	0.000236	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000161	0.000236	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000159	0.000233	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000159	0.000233	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000158	0.000232	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000158	0.000232	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000158	0.000232	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ABCC8—type 1 diabetes mellitus	0.000158	0.000231	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000157	0.000231	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	0.000157	0.000231	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000156	0.000228	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000155	0.000228	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000155	0.000227	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000154	0.000225	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000153	0.000225	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—HBA1—type 1 diabetes mellitus	0.000153	0.000225	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000153	0.000224	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000153	0.000224	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—APOC3—type 1 diabetes mellitus	0.000152	0.000223	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000151	0.000221	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000151	0.000221	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.00015	0.000221	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GSTT1—type 1 diabetes mellitus	0.00015	0.000219	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000148	0.000218	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	0.000148	0.000217	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000148	0.000217	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000147	0.000216	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000147	0.000215	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000147	0.000215	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000146	0.000215	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—IL6—type 1 diabetes mellitus	0.000146	0.000214	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000144	0.000212	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000144	0.000211	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000143	0.00021	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000143	0.00021	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—IL6—type 1 diabetes mellitus	0.000142	0.000208	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000141	0.000207	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000141	0.000207	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000138	0.000202	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000138	0.000202	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000137	0.000201	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000137	0.000201	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000137	0.000201	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000137	0.0002	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000136	0.0002	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000134	0.000197	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000133	0.000196	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000132	0.000194	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000132	0.000193	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000131	0.000193	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	0.000128	0.000188	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000126	0.000184	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000125	0.000183	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000125	0.000183	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ITPR3—type 1 diabetes mellitus	0.000124	0.000182	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000124	0.000182	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000122	0.000179	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00012	0.000177	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.00012	0.000176	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.00012	0.000176	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.00012	0.000176	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL2—type 1 diabetes mellitus	0.00012	0.000175	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00012	0.000175	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GCG—type 1 diabetes mellitus	0.000119	0.000175	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000119	0.000175	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000119	0.000174	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—HBA1—type 1 diabetes mellitus	0.000117	0.000172	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000117	0.000171	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000116	0.000171	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—APOC3—type 1 diabetes mellitus	0.000116	0.00017	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000116	0.00017	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000116	0.00017	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000115	0.000169	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000115	0.000169	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000115	0.000169	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000115	0.000169	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GSTT1—type 1 diabetes mellitus	0.000114	0.000167	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000114	0.000167	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000112	0.000164	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000111	0.000163	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000111	0.000163	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.00011	0.000162	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.00011	0.000161	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000109	0.00016	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000109	0.00016	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000109	0.000159	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ITPR3—type 1 diabetes mellitus	0.000105	0.000154	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000104	0.000153	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	0.000104	0.000152	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000102	0.00015	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SST—type 1 diabetes mellitus	0.000102	0.000149	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000102	0.000149	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000101	0.000149	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000101	0.000148	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000101	0.000148	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CAT—type 1 diabetes mellitus	0.000101	0.000148	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000101	0.000148	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000101	0.000148	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.0001	0.000147	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—HBA1—type 1 diabetes mellitus	9.9e-05	0.000145	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—APOC3—type 1 diabetes mellitus	9.84e-05	0.000144	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	9.76e-05	0.000143	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	9.74e-05	0.000143	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GSTT1—type 1 diabetes mellitus	9.66e-05	0.000142	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CD80—type 1 diabetes mellitus	9.59e-05	0.000141	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	9.31e-05	0.000137	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	9.25e-05	0.000136	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	9.16e-05	0.000134	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—EGFR—type 1 diabetes mellitus	9.15e-05	0.000134	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GCG—type 1 diabetes mellitus	9.09e-05	0.000133	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—INS—type 1 diabetes mellitus	9.06e-05	0.000133	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GCG—type 1 diabetes mellitus	9.06e-05	0.000133	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	8.9e-05	0.000131	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.79e-05	0.000129	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.77e-05	0.000129	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.72e-05	0.000128	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	8.72e-05	0.000128	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	8.64e-05	0.000127	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	8.62e-05	0.000126	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	8.57e-05	0.000126	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	8.56e-05	0.000126	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	8.52e-05	0.000125	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VAV1—type 1 diabetes mellitus	8.47e-05	0.000124	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	8.46e-05	0.000124	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	8.45e-05	0.000124	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	8.44e-05	0.000124	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	8.42e-05	0.000123	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CD80—type 1 diabetes mellitus	8.41e-05	0.000123	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.1e-05	0.000119	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	8.05e-05	0.000118	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	8e-05	0.000117	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.95e-05	0.000117	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—INS—type 1 diabetes mellitus	7.95e-05	0.000117	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	7.86e-05	0.000115	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.7e-05	0.000113	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GCG—type 1 diabetes mellitus	7.7e-05	0.000113	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CAT—type 1 diabetes mellitus	7.7e-05	0.000113	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.69e-05	0.000113	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF2—type 1 diabetes mellitus	7.67e-05	0.000112	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.65e-05	0.000112	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CD86—type 1 diabetes mellitus	7.38e-05	0.000108	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	7.37e-05	0.000108	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7.25e-05	0.000106	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	7.11e-05	0.000104	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.1e-05	0.000104	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	7.05e-05	0.000103	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL6—type 1 diabetes mellitus	7.03e-05	0.000103	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.01e-05	0.000103	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.97e-05	0.000102	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.75e-05	9.9e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	6.74e-05	9.88e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—INS—type 1 diabetes mellitus	6.72e-05	9.85e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	6.71e-05	9.84e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.7e-05	9.83e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—INS—type 1 diabetes mellitus	6.7e-05	9.82e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	6.69e-05	9.81e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.66e-05	9.77e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.55e-05	9.61e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	6.52e-05	9.56e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.5e-05	9.53e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.46e-05	9.48e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.45e-05	9.47e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.4e-05	9.4e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	6.26e-05	9.19e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ALB—type 1 diabetes mellitus	6.14e-05	9.01e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	6e-05	8.8e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.92e-05	8.68e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2—type 1 diabetes mellitus	5.91e-05	8.67e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.89e-05	8.64e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.88e-05	8.62e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—NOS3—type 1 diabetes mellitus	5.87e-05	8.61e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	5.68e-05	8.33e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.67e-05	8.32e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	5.64e-05	8.28e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	5.39e-05	7.9e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	5.31e-05	7.79e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	5.3e-05	7.78e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	5.28e-05	7.75e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	5.18e-05	7.61e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.15e-05	7.56e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—INS—type 1 diabetes mellitus	5.11e-05	7.49e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	5.09e-05	7.47e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	5e-05	7.34e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.99e-05	7.32e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.97e-05	7.29e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.97e-05	7.29e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.92e-05	7.22e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.9e-05	7.19e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ALB—type 1 diabetes mellitus	4.68e-05	6.87e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.55e-05	6.67e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.52e-05	6.63e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—NOS3—type 1 diabetes mellitus	4.48e-05	6.57e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.46e-05	6.55e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	4.32e-05	6.35e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.2e-05	6.16e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	4.13e-05	6.06e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	3.96e-05	5.82e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.96e-05	5.81e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.82e-05	5.6e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	3.79e-05	5.56e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.79e-05	5.56e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	3.78e-05	5.55e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—INS—type 1 diabetes mellitus	3.77e-05	5.53e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.76e-05	5.52e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	3.52e-05	5.16e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	3.5e-05	5.13e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.47e-05	5.09e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	3.45e-05	5.07e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	3.3e-05	4.85e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	3.23e-05	4.73e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.18e-05	4.67e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	3.09e-05	4.53e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.93e-05	4.31e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.89e-05	4.25e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	2.32e-05	3.41e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.22e-05	3.26e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	2.13e-05	3.12e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	2.04e-05	2.99e-05	CbGpPWpGaD
